Tim‐Wai Chan
Papers
1
Total Citations
8
H-Index
1
About
Dr. Tim-Wai Chan is a leading urological oncologist whose work has been pivotal in reshaping prostate cancer care, particularly during global health crises. His research focuses on the intersection of urological oncology, public health emergency preparedness, and interdisciplinary patient management. Dr. Chan’s most notable contribution is the landmark 2021 paper, “Prostate cancer management in the era of COVID‐19: Recommendations from the Hong Kong Urological Association and Hong Kong Society of Uro‐oncology,” which has garnered 8 citations. This work provided critical, evidence-based guidelines for managing prostate cancer patients across all disease stages during the pandemic, addressing urgent needs for coordinated care among urologists, oncologists, and radiologists. By establishing clear protocols for triaging treatments, delaying non-essential procedures, and adapting telemedicine, Dr. Chan’s recommendations helped maintain high-quality, safe care for patients while minimizing COVID-19 exposure risks. His leadership in synthesizing expert consensus during a time of uncertainty has made him a trusted voice in crisis-driven oncology, demonstrating how clinical expertise can be rapidly mobilized to protect vulnerable populations. Dr. Chan’s work continues to influence pandemic-era oncology protocols and underscores the importance of adaptable, patient-centered care in urological oncology.
Research Focus
Key Achievements
Top Papers
- 1